TRICLOS Drug Patent Profile
✉ Email this page to a colleague
When do Triclos patents expire, and when can generic versions of Triclos launch?
Triclos is a drug marketed by Sanofi Aventis Us and is included in two NDAs.
The generic ingredient in TRICLOS is triclofos sodium. Additional details are available on the triclofos sodium profile page.
Summary for TRICLOS
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 18 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TRICLOS at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for TRICLOS
US Patents and Regulatory Information for TRICLOS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | TRICLOS | triclofos sodium | SOLUTION;ORAL | 016830-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sanofi Aventis Us | TRICLOS | triclofos sodium | TABLET;ORAL | 016809-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |